PIM
BMRN icon

Partner Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Partner Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$451K Sell
5,329
-24,012
-82% -$1.81M 3.24% 13
2019
Q3 		$1.98M Buy
29,341
+3,731
+15% +$287K 3.49% 6
2019
Q2 		$2.19M Buy
+25,610
New +$2.19M 3.05% 9
2017
Q3 		– Sell
-3,973
Closed -$361K – 88
2017
Q2 		$361K Sell
3,973
-17,991
-82% -$1.64M 0.53% 58
2017
Q1 		$1.93M Sell
21,964
-2,510
-10% -$223K 2.53% 9
2016
Q4 		$2.03M Buy
24,474
+8,839
+57% +$760K 3.17% 7
2016
Q3 		$1.45M Buy
15,635
+3,883
+33% +$366K 2.24% 12
2016
Q2 		$914K Buy
+11,752
New +$999K 1.9% 28

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return